The role of methysergide in migraine and cluster headache treatment worldwide – A survey in members of the International Headache Society

@article{MacGregor2017TheRO,
  title={The role of methysergide in migraine and cluster headache treatment worldwide – A survey in members of the International Headache Society},
  author={E. Anne MacGregor and Stefan Evers},
  journal={Cephalalgia},
  year={2017},
  volume={37},
  pages={1106 - 1108}
}
Background Methysergide has been as an effective treatment for migraine and cluster headache for over 50 years but has recently been investigated by the European Medicines Agency due to safety concerns. Methods To assess the need for continuing availability of methysergide, the International Headache Society performed an electronic survey among their members. Results The survey revealed that 71.3% of all respondents had ever prescribed methysergide and 79.8% would prescribe it if it were to… 

Tables from this paper

Primaries non-migraine headaches treatment: a review

In the “headache world,” great attention has always been paid to migraine patients, especially for the research and development of new therapies, but in recent years, neuromodulation techniques have also been affirming themselves, which represent a more possibility for forms of headache that are often very disabling and resistant to common analgesics.

Current advances in the management of cluster headaches

To improve the evidence for efficacy of currently available or emerging treatments for cluster headache, it is proposed that the design of the clinical trials for CH needs to be radically reviewed to allow more patients to participate.

Emerging treatments for cluster headache: hopes and disappointments

  • D. Magis
  • Medicine
    Current opinion in neurology
  • 2019
These novel approaches provide additional alternatives to conventional cluster headache management, but results obtained in chronic forms are often disappointing.

Pharmacotherapy for Cluster Headache

A new addition to the preventive treatment options in episodic cluster headache is galcanezumab, although the long-term effects remain unknown.

Treatment of Cluster Headache

This review primarily focuses on therapies with highest quality of evidence and also on the emerging therapies for CH, including abortive therapy, transitional therapy, and preventive therapy.

The impact of CGRPergic monoclonal antibodies on prophylactic antimigraine therapy and potential adverse events

This review considers the current knowledge on the mechanisms of action, specificity, safety, and efficacy of the above mAbs as prophylactic antimigraine agents, and examines the possible adverse events that these agents may trigger.

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research

It is concluded that while most anecdotal reports focus on the positive experiences with microdosing, future research should also focus on potential risks of (multiple) administrations of a psychedelic in low doses, and (pre)clinical studies including biological as well as cognitive parameters have to be conducted to shed light on the potential negative consequencesmicrodosing could have.

The effect of serotonin on penicillin-induced epileptiform activity

The electrophysiological data suggest that serotonin 5-HT2 receptors have an important role in controlling penicillin-induced epileptiform activity in the rat.

5‐hydroxytryptamine in migraine: The puzzling role of ionotropic 5‐HT3 receptor in the context of established therapeutic effect of metabotropic 5‐HT1 subtypes

Clinical data do not clearly support the applicability of currently available 5‐ HT3 antagonists to migraine treatment, and the presence of 5‐HT3 receptors on inhibitory interneurons dampening the excitatory drive might be the reasons for this.

Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development

The 5-HT1F receptor agonist lasmiditan, a drug acting through non-vasoconstrictive mechanisms, represents a promising safe, effective and tolerated acute migraine therapy also for patients at cardiovascular risk.

References

SHOWING 1-10 OF 13 REFERENCES

EFNS guidelines on the treatment of cluster headache and other trigeminal‐autonomic cephalalgias

Large series suggest that lamotrigine is the most effective preventive agent, with topiramate and gabapentin also being useful in treatment of SUNCT syndrome, and surgical procedures, although in part promising, require further scientific evaluation.

Canadian Headache Society guideline for migraine prophylaxis.

There is good evidence from randomized controlled trials for use of a number of different prophylactic medications in patients with migraine, and medication choice for an individual patient requires careful consideration of patient clinical features.

History of Methysergide in Migraine

The rise, fall and subsequent use of methysergide as a third-choice drug of the first effective migraine prophylactic, methylergometrine, is described.

METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS.

  • J. Graham
  • Medicine
    The New England journal of medicine
  • 1964
The mechanism whereby methysergide prevents headache is not yet fully determined, but one is that the drug is a powerful serotonin antagonist and may act by neutralizing the effects of serotonin either in the blood vessels and tissues or in the central nervous system.

Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review)

This practice parameter summarizes the results from the four evidence-based reviews on the management of patients with migraine: specifically, acute, preventive, and nonpharmacologic treatments for migraine, and the role of neuroimaging in patients with headache.

Italian guidelines for primary headaches: 2012 revised version

The first edition of the Italian diagnostic and therapeutic guidelines for primary headaches in adults was published in J Headache Pain 2(Suppl. 1):105–190 in 2001 and a section was dedicated to non-pharmacological treatment.

Reference programme: Diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012

The guideline first describes how to examine and diagnose the headache patient and how headache treatment is organised in Denmark, followed by individual sections on the characteristics, diagnosis, differential diagnosis and treatment of each of the major headache disorders and trigeminal neuralgia.

Methysergide

Methysergide can induce retroperitoneal fibrosis and pleural and heart valve fibrosis with an estimated incidence of 1 in 5,000 treated patients, therefore, it should be reserved for severe cases in which other migraine preventive drugs are not effective.

Revised French guidelines for the diagnosis and management of migraine in adults and children

This article is a peer-reviewed and revised translation from French and for citations please use also the following reference of the original recommendations: Lanteri-Minet M, Valade D, Geraud G, Lucas C, Donnet A.

EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force

Migraine is one of the most frequent disabling neurological conditions with a major impact on the patients’ quality of life and the use of medication to treat it is a major concern.